Company / Working Capital
GYRE THERAPEUTICS, INC. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$84.1M
FY2025
5-year range
$37.2M / $84.1M
FY2021-FY2025
Trend
+85.7%
vs FY2024
Sector context
#199 of 213
Health Care
What the data says
Among 213 Health Care companies, GYRE THERAPEUTICS, INC. is in the bottom 7% for working capital. Working Capital has fluctuated over the past 10 years, ranging from $16M in FY2016 to $119M in FY2018.
Based on SEC 10-K filings.
$84M in FY2025 with a 5-year CAGR of +3.2%.
Improved from $37M to $84M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +31.0%
- 5-Year CAGR
- +3.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 213This company $84.1M Sector average $934.6M
▼
-91.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.2%, indicating consistent growth.
- In FY2025, working capital increased 85.7% year-over-year.
- Ranks #199 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2018.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $84.1M | +85.7% |
| FY2024 | $45.3M | +21.8% |
| FY2023 | $37.2M | -0.6% |
| FY2022 | $37.4M | +0.3% |
| FY2021 | $37.3M | -48.0% |
| FY2020 | $71.7M | +6.8% |
| FY2019 | $67.2M | -43.6% |
| FY2018 | $119.2M | +292.5% |
| FY2017 | $30.4M | +95.2% |
| FY2016 | $15.6M | -49.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026